recombinant immunotoxin (BioSavita)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant immunotoxin (BioSavita)

Drug Alias NameEGP 2 specific single chain antibody plus GO enzyme based immunotoxin (ApoLife)glucose oxidase-based immunotoxin (ApoLife)recombinant immunotoxin (ApoLife)

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiosavita

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiosavita

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A